|
SNX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.93869398102242E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.39117622871754E-12 |
| Normal-vs-Stage2 |
3.147800E-02 |
| Normal-vs-Stage3 |
3.56270000001491E-06 |
| Normal-vs-Stage4 |
1.152750E-04 |
| Stage1-vs-Stage2 |
3.423600E-02 |
| Stage1-vs-Stage3 |
7.940100E-02 |
| Stage1-vs-Stage4 |
2.602600E-01 |
| Stage2-vs-Stage3 |
3.027000E-01 |
| Stage2-vs-Stage4 |
2.629600E-01 |
| Stage3-vs-Stage4 |
7.864800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.90263385444223E-12 |
| Normal-vs-AfricanAmerican |
2.049000E-04 |
| Normal-vs-Asian |
1.431550E-04 |
| Caucasian-vs-AfricanAmerican |
6.341800E-02 |
| Caucasian-vs-Asian |
7.497400E-01 |
| AfricanAmerican-vs-Asian |
1.045650E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.03219999956362E-07 |
| Normal-vs-Female |
9.68758406827419E-12 |
| Male-vs-Female |
5.213600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.89468490580703E-12 |
| Normal-vs-Age(41-60Yrs) |
1.7319999878751E-09 |
| Normal-vs-Age(61-80Yrs) |
1.439510E-02 |
| Normal-vs-Age(81-100Yrs) |
6.279600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.286980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.13120000003286E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.312300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.595100E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.084000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.186600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.009800E-01 |
| Classical-VS-Follicular |
1.92659999997957E-06 |
| Classical-VS-Other |
2.509400E-01 |
| Classical-VS-Normal |
3.33066907387547E-15 |
| Tall-VS-Follicular |
8.677500E-03 |
| Tall-VS-Other |
3.514800E-01 |
| Tall-VS-Normal |
3.98340000000719E-05 |
| Follicular-VS-Other |
6.991200E-01 |
| Follicular-VS-Normal |
1.290000E-01 |
| Other-VS-Normal |
4.131200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70934000000011E-05 |
| Normal-vs-N1 |
3.84250000000641E-05 |
| N0-vs-N1 |
1.524220E-01 |
|
|
